Status
Conditions
Treatments
About
The purpose of this study is to support the safety and performance assessment of Air Optix Night and Day Aqua (AONDA) soft contact lenses for therapeutic use in accordance with updated EU Medical Device Regulation (MDR) requirements.
Full description
In this retrospective, real world evidence study, the subjects wore Air Optix Night and Day Aqua (AONDA) soft contact lenses or PureVision 2 (PV2) soft contact lenses as a therapeutic lens for the treatment of a corneal condition with pain in one or both eyes as part of their eye care professional's treatment and management plan.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
168 participants in 2 patient groups
Loading...
Central trial contact
Alcon Call Center
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal